TAAP-2: Advancing Research on Age-Related Macular Degeneration in Asia
By
Iliyah
Summary
The article discusses the Translational Asian Age-related Macular Degeneration Programme Phase 2 (TAAP-2), a research initiative addressing age-related macular degeneration (AMD) in Asia's rapidly aging population. AMD is a leading cause of vision loss that erodes central vision, affecting daily activities like reading and driving. TAAP-2 represents an evolution in scientific scope and clinical ambition to confront this disease. However, the provided content appears fragmented, mixing content about Recurrent Aphthous Stomatitis (RAS) with the AMD topic, suggesting possible content extraction issues.
Source
bskyTAAP-2: Advancing Research on Age-Related Macular Degeneration in Asiascientia.globalKey quotes
· 4 pulledAge-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide.
In Asia, where populations are ageing rapidly, its impact is particularly profound.
For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult.
TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.
You might also wanna read
Omega-3 fatty acids linked to lower myopia risk in children, Hong Kong study finds
A population-based study of 1,005 Chinese children aged 6-8 years from the Hong Kong Children Eye Study found that dietary intake of omega-3

FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea
The Global Myopia Epidemic: Understanding Vision Loss and Prevention Strategies
The article discusses the global myopia (nearsightedness) epidemic, highlighting that vision loss is becoming increasingly common worldwide.
AI Foundation Model Improves Ophthalmologist Diagnostic Accuracy in Randomized Controlled Trial
Researchers developed EyeFM, a multimodal vision-language eyecare foundation model trained on 14.5 million ocular images from global dataset
Egg Intake and the Incidence of Alzheimer's Disease in Adventist Health Study-2
Method to reverse cellular ageing is about to be tested in humans
Comments
Sign in to join the conversation.
No comments yet. Be the first.
